About E3 ubiquitin-protein ligase makorin-3
E3 ubiquitin-protein ligase makorin-3 (MKRN3) is a protein
from Homo sapiens identified by UniProt accession
Q13064, 507 residues long.
MolForge cross-references it against 0 known binders and
135 disease associations.
Target properties
| Protein name | E3 ubiquitin-protein ligase makorin-3 |
| UniProt accession | Q13064 |
| Gene | MKRN3 |
| Organism | Homo sapiens |
| Length | 507 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (135)
Diseases linked to this target (Open Targets).
- precocious puberty, central, 2 · score 0.68
- age at menarche · score 0.41
- viral load · score 0.32
- body height · score 0.20
- genetic disorder · score 0.19
- Central precocious puberty · score 0.11
- head and neck squamous cell carcinoma · score 0.08
- non-small cell lung carcinoma · score 0.08
- lung cancer · score 0.07
- 46,XX gonadal dysgenesis · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13064-F1 | alphafold | PREDICTED | 62.90 | — |
Amino-acid sequence (507 residues)
MEEPAAPSEA HEAAGAQAGA EAAREGVSGP DLPVCEPSGE SAAPDSALPH AARGWAPFPV APVPAHLRRG GLRPAPASGG GAWPSPLPSR SSGIWTKQII CRYYIHGQCK EGENCRYSHD LSGRKMATEG GVSPPGASAG GGPSTAAHIE PPTQEVAEAP PAASSLSLPV IGSAAERGFF EAERDNADRG AAGGAGVESW ADAIEFVPGQ PYRGRWVASA PEAPLQSSET ERKQMAVGSG LRFCYYASRG VCFRGESCMY LHGDICDMCG LQTLHPMDAA QREEHMRACI EAHEKDMELS FAVQRGMDKV CGICMEVVYE KANPNDRRFG ILSNCNHSFC IRCIRRWRSA RQFENRIVKS CPQCRVTSEL VIPSEFWVEE EEEKQKLIQQ YKEAMSNKAC RYFAEGRGNC PFGDTCFYKH EYPEGWGDEP PGPGGGSFSA YWHQLVEPVR MGEGNMLYKS IKKELVVLRL ASLLFKRFLS LRDELPFSED QWDLLHYELE EYFNLIL
Explore E3 ubiquitin-protein ligase makorin-3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets